Broadwood Partners, L.P. Purchases 249,503 Shares of STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical (NASDAQ:STAA - Get Free Report) major shareholder Broadwood Partners, L.P. purchased 249,503 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average cost of $16.64 per share, with a total value of $4,151,729.92. Following the completion of the transaction, the insider now owns 11,953,198 shares in the company, valued at $198,901,214.72. This trade represents a 2.13 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, February 27th, Broadwood Partners, L.P. bought 259,316 shares of STAAR Surgical stock. The shares were acquired at an average cost of $17.05 per share, with a total value of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. purchased 36,532 shares of STAAR Surgical stock. The stock was bought at an average cost of $15.49 per share, for a total transaction of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. acquired 259,616 shares of STAAR Surgical stock. The shares were bought at an average cost of $14.96 per share, with a total value of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. bought 8,221 shares of STAAR Surgical stock. The stock was bought at an average cost of $21.50 per share, for a total transaction of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. purchased 21,155 shares of STAAR Surgical stock. The shares were bought at an average price of $21.46 per share, with a total value of $453,986.30.
• On Wednesday, December 18th, Broadwood Partners, L.P. purchased 23,000 shares of STAAR Surgical stock. The stock was purchased at an average price of $24.33 per share, for a total transaction of $559,590.00.
• On Monday, December 16th, Broadwood Partners, L.P. acquired 53,500 shares of STAAR Surgical stock. The shares were purchased at an average price of $24.24 per share, with a total value of $1,296,840.00.

STAAR Surgical Stock Performance

Shares of STAA stock traded up $0.42 on Friday, reaching $18.34. The stock had a trading volume of 1,300,501 shares, compared to its average volume of 1,109,182. STAAR Surgical has a 1 year low of $13.50 and a 1 year high of $52.68. The stock has a market cap of $904.62 million, a P/E ratio of -44.73 and a beta of 0.66. The company has a 50 day simple moving average of $21.14 and a 200 day simple moving average of $26.91.

Remove Ads

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on STAA. Jefferies Financial Group downgraded shares of STAAR Surgical from a "buy" rating to a "hold" rating in a research note on Wednesday, February 12th. Stifel Nicolaus cut their target price on STAAR Surgical from $38.00 to $20.00 and set a "buy" rating on the stock in a research note on Wednesday, February 12th. Needham & Company LLC reissued a "hold" rating on shares of STAAR Surgical in a report on Thursday, February 27th. BTIG Research downgraded STAAR Surgical from a "buy" rating to a "neutral" rating in a report on Wednesday, February 12th. Finally, Stephens reaffirmed an "equal weight" rating and set a $28.00 price objective on shares of STAAR Surgical in a research report on Wednesday, February 12th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat.com, STAAR Surgical presently has a consensus rating of "Hold" and an average target price of $26.86.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Broadwood Capital Inc. grew its position in shares of STAAR Surgical by 0.7% during the 4th quarter. Broadwood Capital Inc. now owns 10,848,631 shares of the medical instruments supplier's stock valued at $263,513,000 after acquiring an additional 80,200 shares during the period. Vanguard Group Inc. raised its stake in STAAR Surgical by 5.8% during the 4th quarter. Vanguard Group Inc. now owns 5,855,570 shares of the medical instruments supplier's stock valued at $142,232,000 after purchasing an additional 319,441 shares during the period. State Street Corp lifted its holdings in shares of STAAR Surgical by 0.5% in the third quarter. State Street Corp now owns 1,940,567 shares of the medical instruments supplier's stock worth $72,092,000 after buying an additional 10,430 shares in the last quarter. Resona Asset Management Co. Ltd. purchased a new stake in STAAR Surgical in the 4th quarter worth $36,411,000. Finally, Geode Capital Management LLC boosted its stake in STAAR Surgical by 2.7% during the third quarter. Geode Capital Management LLC now owns 1,174,499 shares of the medical instruments supplier's stock valued at $43,641,000 after buying an additional 31,212 shares during the last quarter. Institutional investors own 96.70% of the company's stock.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.